Skip to main content
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will be devoted to a single timely topic, with series of in-depth reviews, written by leaders in the field, covering a range of current topics on drug targets. These issues will be organized and led by a guest editor who is a recognized expert in the overall topic. As the discovery, identification, characterisation and validation of novel human drug targets for drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Publisher: Bentham Science Publishers

More about this publication?
Volume 10, Number 1, 2009

Articles

Favourites:
ADD

NPY Signalling Pathway in Bone Homeostasis: Y1 Receptor as a Potential Drug Target
pp. 9-19(11)
Authors: Sousa, D. M.; Herzog, H.; Lamghari, M.

Favourites:
ADD

Role of ARBs in the Blood Hypertension Therapy and Prevention of Cardiovascular Events
pp. 20-25(6)
Authors: Novo, S.; Lunetta, M.; Evola, S.; Novo, G.

Favourites:
ADD

Monoclonal Antibodies in the Treatment of Systemic Lupus Erythematosus
pp. 26-37(12)
Authors: Robak, Ewa; Robak, Tadeusz

Favourites:
ADD

PDGF-D Signaling: A Novel Target in Cancer Therapy
pp. 38-41(4)
Authors: Wang, Zhiwei; Kong, Dejuan; Li, Yiwei; Sarkar, Fazlul H.

Favourites:
ADD
Favourites:
ADD

Pathophysiology of Sepsis in the Elderly: Clinical Impact and Therapeutic Considerations
pp. 60-70(11)
Authors: De Gaudio, A. R.; Rinaldi, S.; Chelazzi, C.; Borracci, T.

Favourites:
ADD

Emerging Drug Candidates of Dipeptidyl Peptidase IV (DPP IV) Inhibitor Class for the Treatment of Type 2 Diabetes
pp. 71-87(17)
Authors: Gupta, Rajesh; Walunj, Sameer S.; Tokala, Ranjeet K.; Parsa, Kishore V.L.; Singh, Santosh K.; Pal, Manojit

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content